Dymon Asia Capital (Singapore)’s Merck MRK Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.01M	Buy	31,173 +21,173	+212%	+$2.48M	0.17%	85
2026 Q1	$1.2M	Sell	10,000 -12,000	-55%	-$1.39M	0.12%	164
2025 Q4	$2.32M	Buy	+22,000	New	+$2.07M	0.23%	89
2024 Q3	–	Sell	-5,000	Closed	-$619K	–	113
2024 Q2	$619K	Sell	5,000 -2,000	-29%	-$258K	0.16%	74
2024 Q1	$924K	Buy	+7,000	New	+$863K	0.2%	79

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s MRK Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) increased its Merck (MRK) stake by 212% in Q2 2026, buying an estimated $2.48M and bringing the position to 31,173 shares worth $4.01M. The position accounts for 0.17% of the portfolio, ranked #85.

Dymon Asia Capital (Singapore) first reported a position in MRK in Q1 2024 and has held it in 5 quarters since. 1,879 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Dymon Asia Capital (Singapore) held 31,173 shares of Merck worth $4.01M as of Q2 2026.
Dymon Asia Capital (Singapore) bought 21,173 Merck shares in Q2 2026, an estimated $2.48M.
Merck made up 0.17% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #85 holding.
Dymon Asia Capital (Singapore) first reported a position in Merck in Q1 2024 and has held it in 5 quarters since.
1,879 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.